Navigation Links
Pandemic vaccination did not increase risk of fetal death
Date:1/17/2013

With the rapid progression of molecular biology and genetics, and the subsequent emergence of many new targets, emerging targets & therapeutics provides new opportunities for the prevention and treatment of several major disease systems. The 4th Cancer Targets & Therapeutics Conference, taking place on February 25-26, 2013 in Las Vegas, NV will continue to be a premier event for translational researchers, preclinical scientists and managers, and those carrying out early phase clinical trials, working to identify and exploit advances in the field in order to deliver products with a meaningful clinical impact. Both cutting-edge researchers and those who guide its commercial development will be on-hand to share their knowledge and insights as to how therapeutic cancer targets are identified, and how this research translates into meaningful therapeutics that benefit patients living with cancer.

Attendees will learn about:

  • Important progress in key aspects of antibody, vaccine, and cell-based therapies being developed and evaluated in clinical trials for the immunotherapy of cancer

  • How cellular pathways of protein processing and pivotal cell-death pathways are being targeted by new Therapies New therapeutic targets in epigenetic and newly described metabolic pathways that serve as new pathways for drug discovery

  • Advances in targeting angiogenesis

  • Important new animal models for target validation

  • New approaches to drug-conjugates and to dose evaluation for effective therapy

Preliminary Sessions for 2013 Agenda:

  • Novel Kinase Inhibitors & Beyond the Kinome

  • Functional Genomics & Future Cancer targets

  • Novel Antibody-based Modalities

  • Progress in Cancer Immunotherapy

  • Cancer Stem Cells, Metabolism, Cancer Epigenetics

  • Novel Advances & Technologies in Oncology


'/>"/>

Contact: Press Officer
47-210-78300
Norwegian Institute of Public Health
Source:Eurekalert

Page: 1

Related biology news :

1. Improving equine health: Research studies vaccinations to protect newborn foals
2. The effect of treatment with antibiotics and vaccination against Q fever in sheep
3. Teens susceptible to hepatitis B infection despite vaccination as infants
4. Increase in Arctic shipping poses risk to marine mammals
5. Columbia Engineering and Penn researchers increase speed of single-molecule measurements
6. Fertilizer use responsible for increase in nitrous oxide in atmosphere
7. NIST/UMass study finds evidence nanoparticles may increase plant DNA damage
8. Study finds soda consumption increases overall stroke risk
9. Scientists have discovered genes that increase the risk of osteoporosis and fractures
10. Family history of liver cancer increases risk of developing the disease
11. Research shows how PCBs promote dendrite growth, may increase autism risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2015)... Research and Markets ( http://www.researchandmarkets.com/research/rzzp3v/global_outlook_of ) ... Outlook of the Biometrics Industry 2015 " ... global biometrics market is likely to witness significant ... to the uptake of multiple technologies available. The ... the growth of biometrics in existing applications as ...
(Date:7/13/2015)... 13, 2015 Synaptics Inc. (NASDAQ: ... solutions, today announced sampling of ClearPad ® ... integration (TDDI) product targeting smartphones and tablets. This ... Synaptics , best-in-class touch controller IP and ... developed in the company,s Japan Design Center. TDDI ...
(Date:7/9/2015)... SAN JOSE, Calif. , July 9, ... ), the leading developer of human interface ... authentication technology, the industry,s first fully hardware ... innovative Match-in-Sensor secure authentication technology is literally ... pattern storage and biometric matching within the ...
Breaking Biology News(10 mins):Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3
... Polytechnic University of Catalonia (UPC) have developed a method ... impact of storms. The method, which has been applied ... region,s coasts have a high rate of vulnerability to ... "Until now there was no tool for evaluating coastal ...
... Seattle Rice which provides nearly half the daily ... climate change and some catastrophic events by colonizing its seeds ... just-published U.S. Geological Survey-led research shows. In an ... to climatic scourges such as tsunamis and tidal surges that ...
... of nature have long known that crops like corn and ... control this nightly stem elongation, common to most plants, have ... this week,s early online publication of the journal Nature, ... their discovery of a protein complex they call the "evening ...
Cached Biology News:One-third of central Catalan coast is very vulnerable to storm impact 2Climate adaptation of rice 2Climate adaptation of rice 3Biologists discover an 'evening' protein complex that regulates plant growth 2Biologists discover an 'evening' protein complex that regulates plant growth 3Biologists discover an 'evening' protein complex that regulates plant growth 4Biologists discover an 'evening' protein complex that regulates plant growth 5
(Date:7/30/2015)... According to a new market ... PB/PK, PKPD, Trial Design, Toxicity Prediction, In-house, Contract Service), ... by End Users - Global Forecast to 2020", published ... USD 2,107.99 million by 2020 from USD 1,034.93 million ... Browse more than 75 ...
(Date:7/30/2015)... Denmark , July 30, 2015 ... biotechnology company that applies its innovative TransCon technology ... positive top-line results from a six-month Phase 2 ... once-weekly TransCon Growth Hormone in 53 treatment-naïve, pre-pubertal ... "We are extremely pleased with the top-line ...
(Date:7/29/2015)... Sanofi, a global and ... quarter of 2015. CEO Olivier Brandicourt ... in different businesses. Watch video interview ... Topics covered in the interview include:  ... Performance drivers - Diabetes ...
(Date:7/29/2015)... MONTREAL , July 29, 2015 /PRNewswire/ - BioAmber Inc. ... Laurin , the Company,s Chief Financial Officer has resigned.  ... former Chief Financial Officer who retired in December 2014, ... search for a permanent successor.     Andy ... Mr. Laurin and ensure a smooth transition.  Andy was ...
Breaking Biology Technology:Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3
... Marshfield Clinic has reached an agreement to ... TeraMedica , a Milwaukee-based medical informatics company. , ... to integrate all of Marshfield's clinical data, including ... the clinic's electronic medical record. , ,This will ...
... a national reputation for its emerging biotech industry, ... launch pad for intellectual property (IP) lawsuits. , ... In the highly competitive science and technology community, ... tools used to protect discoveries and innovation. The ...
... Baird Venture Partners , the U.S. venture ... on its presence in China by partnering with the Indian ... portfolio companies as they establish a foothold in the Indian ... partner of Baird Venture Partners and director of Baird Private ...
Cached Biology Technology:Rocket docket speeds patent infringement suits 2Rocket docket speeds patent infringement suits 3Rocket docket speeds patent infringement suits 4Rocket docket speeds patent infringement suits 5Visions: Carbone bullish on Wisconsin venture capital 2Visions: Carbone bullish on Wisconsin venture capital 3Visions: Carbone bullish on Wisconsin venture capital 4Visions: Carbone bullish on Wisconsin venture capital 5
... Serum • Mouse serum is collected off the clot ... weeks of age. Available Anticoagulants: N-02: ... K2EDTA N-08: Potassium Oxalate N-10: ... ACD N-07: CPD N-09: ...
Recombinant Mouse Wnt-3a...
Contains 100 positive controls for effective screening of HDAC inhibitors by fluorometric method....
... There are at least 20 structurally ... of the TGF-beta superfamily. BMPs were originally ... bone formation. They are also involved in ... organs. BMPs regulate the growth, differentiation, chemotaxis ...
Biology Products: